GC
AGN

Grimes & Company’s Allergan plc AGN Stock Holding History

Grimes & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,395
Closed -$2.33M – 225
2017
Q3 		$2.33M Buy
11,395
+496
+5% +$115K 0.25% 79
2017
Q2 		$2.65M Sell
10,899
-3,325
-23% -$781K 0.3% 79
2017
Q1 		$3.4M Buy
14,224
+1,799
+14% +$419K 0.37% 68
2016
Q4 		$2.61M Sell
12,425
-8,848
-42% -$1.83M 0.3% 76
2016
Q3 		$4.9M Sell
21,273
-716
-3% -$175K 0.66% 50
2016
Q2 		$5.08M Buy
+21,989
New +$5.07M 0.68% 39

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Grimes & Company's AGN Position: Q4 2017 in Review

Grimes & Company sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 11,395 shares — an estimated $2.33M sold.

Grimes & Company first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $5.08M in Q2 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Grimes & Company reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Grimes & Company sold 11,395 Allergan plc shares in Q4 2017, an estimated $2.33M.
  • Grimes & Company first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Grimes & Company's Allergan plc position peaked at $5.08M in Q2 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Grimes & Company's 13F filing for Q4 2017, filed 5 Feb 2018.